The effect of systemic injection of cyclosporin A on the phosphorylation of the PKC substrates MARCKS and GAP43 in the rat hippocampus

Neuroscience Letters

Volumn 497, Issue 1, 2011, Pages 17-21

  Yi, Heesun ^a,b   Kim, Se Hyun ^b,c   Park, Hong Geun ^a,b   Yu, Hyun Sook ^a,c   Kim, Yong Sik ^a,c  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Calcineurin; Growth associated protein43; Hyperlocomotion; Myristoylated alanine rich C kinase substrate; Protein kinase C

Indexed keywords

CYCLOSPORIN A; MARCKS PROTEIN; NEUROMODULIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HIPPOCAMPUS; IMMUNOREACTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BLOTTING, WESTERN; CALCINEURIN; CYCLOSPORINE; GAP-43 PROTEIN; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MOTOR ACTIVITY; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 79955998386     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.012     Document Type: Article

References (48)

1. Amadio M., Battaini F., Pascale A. The different facets of protein kinases C: old and new players in neuronal signal transduction pathways. Pharmacol. Res. 2006, 54:317-325.
2. Bahi A., Mineur Y.S., Picciotto M.R. Blockade of protein phosphatase 2B activity in the amygdale increases anxiety- and depression-like behaviors in mice. Biol. Psychiatry 2009, 66:1139-1146.
3. Bear M.F., Abraham W.C. Long-term depression in hippocampus. Annu. Rev. Neurosci. 1996, 19:437-462.
4. Bechstein W.O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl. Int. 2000, 13:313-326.
5. Blair J.T., Thompson A.W., Whiting P.H., Davidson R.J.L., Simpson J.G. Toxicity of the immune suppressant cyclosporine A in the rat. J. Pathol. 1982, 138:163-178.
6. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
7. Borlongan C.V., Freeman T.B., Scorcia T.A., Sherman K.A., Olanow W.C., Cahill D.W., Sanberg P.R. Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats. Cell Transplant. 1995, 4:65-73.
8. Chen G., Masana M.I., Manji H.K. Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo. Bipolar Disord. 2000, 2:217-236.
9. Dean B., Opeskin B.K., Pavey G., Hill C., Keks N. Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia. J. Neural Transm. 1997, 104:1371-1381.
10. de Windt L.J., Lim H.W., Haq S., Force T., Molkentin J.D. Calcineurin promotes protein kinase C and c Jin NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 2000, 275:13571-13579.
11. Edgar V.A., Genaro A.M., Cremaschi G., Sterin-Borda L. Fluoxetine action on murine T-lymphocyte proliferation: participation of PKC activation and calcium mobilization. Cell Signal. 1998, 10:721-726.
12. Einat H., Yuan P., Szabo S.T., Dogra S., Manji H.K. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 2007, 55:123-131.
13. Eastwood S.L., Burnet P.W.J., Harrison P. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol. Psychiatry 2005, 57:702-710.
14. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., Tonegawa S. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8993-8998.
15. Gijtenbeek J.M.M., van den Bent M.J., Vecht Ch.J. Cyclosporine neurotoxicity: a review. J. Neurol. 1999, 246:339-346.
16. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathological implications. Psychopharmacology(Berl) 2004, 174:151-162.
17. Huang K.P. Role of protein kinase C in cellular regulation. Biofactors 1990, 2:171-178.
18. Jardemark K.E., Ninan I., Liang X., Wang R.Y. Protein kinase C is involved in clozapine's facilitation of N-methyl-d-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex. Neuroscience 2003, 118:501-1501.
19. Koo Y.J., Kim S.J., Jeon S.H., Kim S.R., Kang U.G., Park J.B., Kim Y.S. Electroconvulsive shock increases the phosphorylation of amphyphusin II in the rat cerebellum. Neurosci. Lett. 2002, 330:135-138.
20. Lensmeyer G.L., Wiebe D.A., Carlson I.H., Subramanian R. Concentration of cyclosporine A and its metabolites in human tissues postmortem. J. Anal. Toxicol. 1991, 15:110-115.
21. Liu Y.C., Storm D.R. Dephosphorylation of neuromodulin by calcineurin. J. Biol. Chem. 1989, 264:12800-12804.
22. Lodge D.J., Grace A.A. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J. Neurosci. 2007, 27:11424-11430.
23. Mathew S.J., Manji H.K., Charney D.S. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008, 33:2080-2092.
24. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., Caron M.G., Tonegawa S. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8987-8992.
25. Mosevitsky M.I. Nerve ending "signal" proteins GAP-43, MARCKS and BASP1. Int. Rev. Cytol. 2005, 245:245-325.
26. Nelson T.J., Sun M.K., Hongpaisan J., Alkon D.L. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur. J. Pharmacol. 2008, 585:76-87.
27. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Conley R.R. Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Arch. Gen. Psychiatry 2004, 61:685-693.
28. Ramakers G.M.J., Pasinelli P., Hens J.J., Gispen W.H., De Graan P.N. Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates. Prog. Neuropsychopharmacol. Biol. Psychiatry 1997, 21:455-486.
29. Rausch J.L., Gillespie C.F., Fei Y., Hobby H.M., Stoming T., Ganapathy V., Leibach F.M. Antidepressant effects on kinase gene expression patterns in rat brain. Neurosci. Lett. 2002, 334:91-94.
30. Richtand N.M., Taylor B., Welge J.A., Ahlbrand R., Ostrander M.M., Burr J., Hayes S., Coolen L.M., Pritchard L.M., Logue A., Herman J.P., McNamara R.K. Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions. Neuropsychopharmacology 2006, 31:77-89.
31. Rushlow W.J., Seah Y.H., Belliveau D.J., Rajakumar N. Changes in calcineurin expression induced in rat brain by the administration of antipsychotics. J. Neurochem. 2005, 94:587-596.
32. Sato Y., Takayanagi Y., Onaka T., Kobayashi E. Impact of cyclosporine upon emotional and social behavior in mice. Transplantation 2007, 83:1365-1370.
33. Schumit U., El-Ela A.A., Guo L.J., Glavinas H., Krajcsi P., Baron J.M., Tillmann C., Hiemke C., Langguth P., Härtter S. Cyclosporine A affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein. J. Neural Transm. 2006, 113:787-801.
34. Seki K., Chen H.C., Huang K.P. Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A. Arch. Biochem. Biophys. 1995, 316:379-673.
35. Serkova N.J., Christians U., Bene L.J. Biochemical mechanisms of cyclosporine neurotoxicity. Mol. Interv. 2004, 4:97-107.
36. Shenolikar S. Protein serine/threonine phosphatases-new avenues for cell regulation. Annu. Rev. Cell Biol. 1994, 10:55-86.
37. Shibasaki F., Hallin U., Uchino H. Calcineurin as a multifunctional regulator. J. Biochem. 2002, 131:1-15.
38. Szabo S.T., Machado-Vieira R., Yuan P., Wang Y., Wei Y., Falke C., Cirelli C., Tononi G., Manji H.K., Du J. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 2009, 56:47-55.
39. Tamminaga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167:1178-1193.
40. Tanaka K., Takahashi J., Motinobu S., Fujimaki K., Tsuji S., Kato K., Ohkawa M., Yamawaki S., Kato N. Imipramine, but not lithium, induces the serine/threonine phosphatase activity of calcineurin without affecting its mRNA expression in the rat brain. Psychopharmacology 2002, 162:339-344.
41. van Dam E.J., Ruiter B., Kamal S., Ramakers G.M., Gispen W.H., de Graan P.N. N-methyl-d-aspartate-induced long-term depression is associated with a decrease in postsynaptic protein kinase C substrate phosphorylation in rat hippocampal slices. Neurosci. Lett. 2002, 320:129-132.
42. Verghese G.M., Johnson J.D., Vasulka C., Haupt D.M., Stumpo D.J., Blackshear P.J. Protein kinase C-mediated phosphorylation and calmodulin binding of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein. J. Biol. Chem. 1994, 269:9361-9367.
43. Victor R.G., Thomas G.D., Marbam D., O'Rourke B. Presynaptic modulation of cortical synaptic activity by calcineurin. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:6269-6273.
44. Wijdicks E.F.M. Neurotoxicity of immunosuppressive drugs. Liver Transpl. 2001, 7:937-942.
45. Wang H.Y., Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol. Psychiatry 1996, 40:568-575.
46. Yakel J.L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol. Sci. 1997, 18:124-134.
47. Zhu Y., Yakel J.L. Calcineurin modulates G protein-mediated inhibition of N-type calcium channels in rat sympathetic neurons. J. Neurophysiol. 1997, 78:1161-1165.
48. Zornoza T., Cano-Cebrian M.J., Miquel M., Aragón C., Polache A., Granero L. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus. Neuropsychopharmacology 2005, 30:843-852.